|
Real-time Estimate
Cboe BZX
10:03:21 2026-10-29 am EDT
|
5-day change | 1st Jan Change | ||
| 327.56 USD | +0.99% |
|
-2.98% | -2.77% |
| Oct. 21 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| Oct. 21 | Baird Adjusts Price Target on Cencora to $375 From $373 | MT |
| Market Cap | 61.89B 55.53B 51.34B 46.5B 86.87B 5,895B 87.92B 614B 245B 3,085B 232B 227B 9,793B | P/E 2026 * |
17.8x | P/E 2027 * | 19.6x |
|---|---|---|---|---|---|
| Enterprise Value | 69.33B 62.2B 57.51B 52.09B 97.31B 6,603B 98.49B 688B 274B 3,455B 260B 255B 10,969B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.19x |
| Free-Float |
61.21% | Yield 2026 * |
0.73% | Yield 2027 * | 0.75% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
London S.E.
| 0HF3 | Delayed | |
|
Tradegate
| ABG | Real-time | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Boerse Muenchen
| ABG | Real-time | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Xetra
| ABG | Delayed | |
|
Wiener Boerse
| ABC | End-of-day quote | |
|
Borsa Italiana
| 1COR | End-of-day quote |
Last Transcript: Cencora, Inc.
| 1 day | -0.31% | ||
| 1 week | -4.72% | ||
| Current month | +8.03% | ||
| 1 month | +6.76% | ||
| 3 months | +1.49% | ||
| 6 months | +3.96% | ||
| Current year | -3.97% |
| 1 week | 320.06 |  | 338.07 |
| 1 month | 295.01 | | 345.46 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 182.75 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.7 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 2024-09-30 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 2026-06-28 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 2024-11-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 2013-05-15 |
Robert Mauch
BRD | Director/Board Member | 59 | 2024-09-30 |
D. Mark Durcan
CHM | Chairman | 64 | 2025-09-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Other | Director | 275 | 0.0001% | ||
| 10/1/26 | Sell | Controller/Auditor | -986 | 0.0005% | ||
| 10/1/26 | Other | Director | 197 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.27% | -4.72% | -3.36% | +72.86% | 61.89B | |
| +1.04% | +2.12% | -18.93% | +10.54% | 178B | |
| +1.02% | +2.15% | -19.13% | +16.07% | 117B | |
| +0.97% | +1.88% | +1.66% | +36.51% | 116B | |
| +1.38% | +1.67% | -43.42% | +7.02% | 91.03B | |
| -0.32% | -0.19% | +10.38% | +83.80% | 55.85B | |
| +1.10% | +0.42% | +5.94% | -22.43% | 53.16B | |
| +0.80% | +1.70% | -11.26% | +43.83% | 44.35B | |
| +1.32% | +0.83% | -1.85% | -7.66% | 33.59B | |
| +0.49% | -2.04% | +13.56% | -11.95% | 29.67B | |
| Average | +0.98% | +0.65% | -6.64% | +22.86% | 77.98B | |
| Weighted average by Cap. | +1.34% | +1.13% | -11.32% | +23.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 302B 280B 253B 473B 32,099B 479B 3,343B 1,331B 16,797B 1,265B 1,238B 53,324B | 352B 316B 292B 264B 494B 33,494B 500B 3,488B 1,389B 17,527B 1,320B 1,292B 55,642B |
| Net income | 3.58B 3.21B 2.97B 2.69B 5.02B 341B 5.09B 35.51B 14.14B 178B 13.44B 13.15B 566B | 2.84B 2.55B 2.36B 2.14B 3.99B 271B 4.04B 28.22B 11.24B 142B 10.68B 10.45B 450B |
| Net Debt | 7.44B 6.67B 6.17B 5.59B 10.44B 708B 10.56B 73.76B 29.38B 371B 27.91B 27.32B 1,177B | 5.95B 5.33B 4.93B 4.47B 8.35B 566B 8.45B 58.97B 23.49B 296B 22.31B 21.84B 941B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | $328.78 | +1.37% | 53,370 |
| 26-10-28 | $324.35 | -0.31% | 1,076,740 |
| 26-10-27 | $325.37 | -1.40% | 1,123,060 |
| 26-10-26 | $330.00 | -0.30% | 993,480 |
| 26-10-23 | $331.00 | -2.21% | 1,168,293 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
